Cardiac Function Test
Cardiac Function Test
Cardiac Function Test
• Tests currently used for evaluation of patients with CAD include stress
electrocardiography (ECG), stress or pharmacologic echocardiography, stress or
pharmacologic myocardial perfusion imaging (MPI), electron beam computed
tomography (EBCT), and positron emission tomography (PET)
• Complete detailed clinical examination is the main part of test.
CHEST X RAY
ECG
Key clinical finding includes rate, rhythm, axis, ischemia, infarction and hypertrophy.
Usually 12 lead ECG is used.
For preoperative assessment ECG should be taken 24-48 hours before surgery to rule out
silent ischemic changes and it also provide a base line for comparison in
operating room before induction as well as post operatively.
Resting ECG is normal in 25-50% of patients with ischemic heart disease
• Characteristic features of ischemia or previous infarction may be present
• Exercise ECG provides a good indication of the degree of cardiac reserve
• 24-hour monitoring is useful in the detection and assessment of arrhythmias
[Ambulatory ECG monitoring (HOLTER]
ECHOCARDIOGRAPHY
• Key clinical findings are segmental wall motion, ejection fraction, valvular
function and congenital anatomic defects.
• Can be performed percutaneously or transoesophageal
• Two-dimensional echocardiography allows assessment of
o Muscle mass
o Ventricular function / ejection fraction
o End-diastolic and end-systolic volumes
o Valvular function
o Segmental defects
• Doppler ultrasound allows assessment of valvular flow and pressure gradients
STRESS ECHOCARDIOGRAPHY
Lung disease
Arthritis
Psychological impairment
COMPUTED TOMOGRAPHY
INVASIVE METHODS
CARDIAC CATHERISATION
• Gold standard in diagnosing cardiac pathology prior to open cardiac
surgery and in finding out coronary vessel pathology.
• Any degree of left ventricular dysfunction, valvular abnormality, severe
pulmonary disease, impaired right ventricular function exists clinically, a
right sided [swan-ganz] catheterization is done otherwise left side is done.
• A 50% reduction in vessel diameter is equivalent to a 75% reduction in
cross-sectional area, and represents a significant stenosis. Left ventricular
ejection fraction, cardiac output, pulmonary vascular resistance and end-
diastolic pressures may be measured during cardiac catheterization. In
valvular lesions, the pressure gradient or regurgitant fraction across the
valve may be estimated.
• Contraindication?
• Women are more likely to have non obstructive or single-vessel disease when
compared with men, which decreases the diagnostic accuracy of stress testing
• Calcium scoring is limited because women tend to have 3- to 5-fold greater
mortality rates for a given calcium score than men,
• SPECT imaging is technically limited in women because breast tissue and
relatively small left ventricle size can generate false-positive results